保健品业

Search documents
交大昂立起诉五名前高管涉嫌违法退保 涉及金额逾2100万元
Zheng Quan Shi Bao Wang· 2025-07-09 14:41
Core Viewpoint - The management of Jiaoda Onlly (交大昂立) has accused five former executives of illegal insurance purchases and refunds, leading to significant financial implications for the company [1][2]. Group 1: Allegations Against Former Executives - The company purchased a total of 3.8 million yuan (approximately 0.54 million USD) in group annuity insurance from Tianan Life in October 2016 and paid 12.84 million yuan (approximately 1.8 million USD) in insurance premiums to Pacific Life from January to June 2018, with the insured being the five former executives [2]. - The five former executives refunded a total of 3.79 million yuan (approximately 0.53 million USD) from Tianan Life and 13.145 million yuan (approximately 1.83 million USD) from Pacific Life, totaling 16.937 million yuan (approximately 2.36 million USD) in refunds [2]. - The company’s assistant president stated that the approval process for these insurance payments lacked necessary documentation, suggesting potential illegalities in the refund process [2]. Group 2: Legal Actions and Financial Impact - In December 2024, the Shanghai Securities Regulatory Bureau issued a warning regarding the company’s inaccurate disclosure of executive compensation in its annual reports for 2016 and 2018 [3]. - The company filed a civil lawsuit against the five former executives for damages amounting to approximately 21.04 million yuan (approximately 2.9 million USD) but later withdrew the lawsuit before the court hearing [3]. - The chairman indicated that the actions of the former executives resulted in a loss of approximately 21 million yuan (approximately 2.9 million USD) to the company, leading to a criminal report filed with the local police [3][4]. Group 3: Business Operations and Client Relationships - The company disclosed that it had significant sales to Hefei Sanzi Yang, totaling 5.1575 million yuan (approximately 0.72 million USD) and 3.1611 million yuan (approximately 0.44 million USD) in the second and third quarters of 2024, respectively, making it the largest customer during that period [5]. - However, by the fourth quarter of 2024, Hefei Sanzi Yang was no longer listed among the top ten customers, and the CEO of Sanzi Yang resigned from the board of Jiaoda Onlly [5][6]. - The chairman mentioned that the company has identified better business opportunities, leading to the cessation of collaboration with Sanzi Yang [6].
(进博故事)直播的流量“澳”秘
Zhong Guo Xin Wen Wang· 2025-06-12 16:26
Core Insights - The Australia-China trade relationship is leveraging live streaming as a new paradigm for cross-border cooperation, particularly highlighted during the 2024 China International Import Expo (CIIE) [1][2]. Group 1: Event Overview - The 2024 CIIE will feature a record number of over 250 Australian companies across various sectors including minerals, food, health, and consumer goods [1]. - Nearly 100 Australian companies are participating for the first time, with 30 of them entering the Chinese market for the first time [1]. Group 2: Economic Impact - The Australian Trade and Investment Commission reported a total transaction value of approximately 3.77 billion AUD (around 14.82 billion RMB) during the expo [2]. - Live streaming has significantly enhanced the visibility and sales potential of Australian products in the Chinese market, with one product's sales increasing fivefold due to live demonstrations [3]. Group 3: Live Streaming as a Tool - Live streaming has become an integral part of the CIIE, with companies utilizing it to engage with consumers and showcase products in real-time [3][5]. - The live streaming initiative has attracted a viewership of nearly 33 million for online broadcasts, indicating a strong consumer interest and engagement [5]. Group 4: Future Prospects - There is an expectation for increased commercial cooperation between Australia and China, with live streaming seen as a key strategy for Australian companies to adapt to market trends [3][5]. - The CIIE is viewed as a significant platform for Australian products to expand their influence in China, with ongoing opportunities for innovation in cross-border cooperation [5].